Continued support is requested to test the hypothesis that CD98 is important in the proliferation and function of cells in injured blood vessels. The applicant will examine the effect of CD98 deletion on the response to arterial injury in vivo and on vascular cell proliferation and sun/ival ex vivo and in vitro. He will use CD98 mutants that specifically couple to integrins or amino acid transporters to examine the relative importance of each in vascular cell proliferation and survival. If integrins are implicated, he will examine the role of CD98 in integrin-dependent signals (e.g. pp125FAK, ERK1/2, PIS Kinase) and conversely will identify the relevant integrins. Finally in collaboration with Core Unit A (Ruggeri) and Project 3 (Ruf) he will examine the effect of CD98 deletion in smooth muscle cells and myeloid cells in the generation of procoagulant activity in vivo and in vitro.
A second Aim will test the hypothesis that shear stress results in localized activation of Protein Kinase A in endothelial cells and that this localized activation directs endothelial cell alignment and migration by phosphorylating integrin aA and other substrates to modify the activity of Rho GTPases. He will use a microfluidic platform in combination with FRET-based biosensors to examine changes in PKA activity, in real time, in migrating vascular cells and in endothelial cells in response to shear stress. A similar approach will be used to assess responses of Rho GTPases using their biosensors and cross correlation and computational multiplexing will be used to examine the spatiotemporal relationship of Rho GTPase activity with protrusion and with PKA activity. He will inhibit PKA activity in a type-specific manner by using type specific AKAPs joined to mitochondrial targeting sequences to sequester either Type I or Type II PKA and examine effects on Rho GTPases, alignment, and cell migration. Finally, he will identify PKA substrates that are important in regulating Rho GTPase activity. These studies, using cutting edge methodologies, will provide new insight Into the mechanisms that regulate the response of vascular cells to vascular injury and will provide detailed mechanistic insight into the control of endothelial cell migration into wounds.
This project proposes to analyze the role of adhesive signaling in the response of vascular cells to vessel injury. The analysis of these signaling events may identify novel means of stabilizing vessel integrity to promote thromboresistance. Thus, these studies are relevant to the prevention of the complications of cardiovascular disease and of vascular interventions
|Subramaniam, Saravanan; Jurk, Kerstin; Hobohm, Lukas et al. (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129:2291-2302|
|Kamikubo, Yuichi; Mendolicchio, G Loredana; Zampolli, Antonella et al. (2017) Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. Blood 130:1661-1670|
|Amar, Arun Paul; Sagare, Abhay P; Zhao, Zhen et al. (2017) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology :|
|Klann, Jane E; Remedios, Kelly A; Kim, Stephanie H et al. (2017) Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool. J Immunol 198:4639-4651|
|Rothmeier, Andrea S; Marchese, Patrizia; Langer, Florian et al. (2017) Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking. Arterioscler Thromb Vasc Biol 37:1323-1331|
|Deguchi, Hiroshi; Navarro, Silvia; Payne, Amanda B et al. (2017) Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases. Res Pract Thromb Haemost 1:33-40|
|Alsultan, Abdulrahman; Gale, Andrew J; Kurban, Kadijah et al. (2016) Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis. Thromb Res 143:17-21|
|Ruf, Wolfram; Rothmeier, Andrea S; Graf, Claudine (2016) Targeting clotting proteins in cancer therapy - progress and challenges. Thromb Res 140 Suppl 1:S1-7|
|Bhat, Vikas; von Drygalski, Annette; Gale, Andrew J et al. (2016) Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa. Thromb Haemost 115:551-61|
|Abplanalp, Wesley T; Conklin, Daniel J; Cantor, Joseph M et al. (2016) Enhanced Integrin ?4?1-Mediated Adhesion Contributes to a Mobilization Defect of Endothelial Progenitor Cells in Diabetes. Diabetes 65:3505-3515|
Showing the most recent 10 out of 422 publications